enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. This Beaten-Down Biotech Stock Just Got Some Good News ... - AOL

    www.aol.com/finance/beaten-down-biotech-stock...

    Since November 2023, CRISPR Therapeutics has been earning approvals for Casgevy, a gene-editing medicine, in various countries and regions. This new coverage could also make it easier once CRISPR ...

  3. This Biotech IPO Stock Aims to Seize a Multibillion-Dollar ...

    www.aol.com/biotech-ipo-stock-aims-seize...

    A newly minted biopharma initial public offering (IPO) has Wall Street analysts rushing to the gates to price it for massive gains.. Artiva Biotherapeutics (NASDAQ: ARTV) is making waves with its ...

  4. US Senate bill targeting China's BGI, WuXi AppTec moves forward

    www.aol.com/news/us-senate-committee-takes-bill...

    (Reuters) -The U.S. Senate's homeland security committee voted on Wednesday to approve a bill that could restrict business with Chinese biotech companies like BGI and WuXi AppTec on national ...

  5. List of largest biomedical companies by market capitalization

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

  6. Biotech Stocks: 14 Things to Know as the VECT Stock IPO ... - AOL

    www.aol.com/news/biotech-stocks-14-things-know...

    Biotech stocks are making headlines on Friday as two companies join the public market via initial public offerings (IPOs) today. Source: Shutterstock Let’s dive into the first of the new biotech ...

  7. Geron Corporation - Wikipedia

    en.wikipedia.org/wiki/Geron_Corporation

    Geron Corporation has sponsored human clinical trials of several potential anti-cancer products. Imetelstat (GRN163L) is a drug that targets telomerase. [13] In studies conducted at Johns Hopkins University, GRN163L was active against both CD138+ and CD138neg cancer stem cells and eliminated the colony forming potential of both by five weeks. [14]

  8. Intellia Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Intellia_Therapeutics

    Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise ...

  9. Moderna cuts sales forecast on weaker vaccine demand

    www.aol.com/finance/moderna-cuts-sales-forecast...

    Moderna cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales for its COVID-19 vaccine.The company now expects $1.5 to $2 billion in revenue ...